|
HolGenTech: Press Releases
Press Release by PRWeb Genome informatics leader Dr. Andras Pellionisz joins the BoA of the global IT Company to break into Industrialization of Genomics ELOGIC Technologies Private Limited is a Company Certified for ISO 9001:2008 by BVQI and ISO 27001:2005 for Security by BSI for years now and is in the process of obtaining an ISO: 50001 Certification for Energy Management System. In the business of Secure Information Management and IT Infrastructure Services Delivery, the Company aims at maintaining an uncompromising level of integrity and character to serve its customers, partners, employees and community, building a network of trust along the way. The company is now foraying into Genome Informatics and Next Gen Seq Data Analysis on the public and private clouds. ELOGIC Technologies announces that Dr. Andras Pellionisz has accepted invitation to join the Advisory Board of ELOGIC Technologies. Dr. Pellionisz is an internationally renowned leader in the field of genome informatics specializing in the geometric unification of neuroscience and genomics. Founder and President of Silicon Valley-based HolGenTech, Inc. in California, he exemplifies the model Andy Grove, senior adviser to Intel, by putting innovation within goal-oriented corporation structure. In his major paper in Springer Handbook (in Press, accepted Nov. 1st 2011) he pairs breakthrough algorithmic development with a blueprint for industrial deployment at a crucial time when the Human Genome Project already impacted the economy by $796 Bn. “We are delighted to welcome Dr. Andras Pellionisz into our Advisory Board. He brings a wealth of leading edge understanding and global contacts in genome informatics that will be invaluable to ELOGIC Technologies as we edge into this major emerging market,” says TD Prakash, Managing Director and Chairman of the Board of ELOGIC Technologies. "This is the formative decision in the long-term co-operation between USA-Silicon valley HolGenTech, Inc. and ELOGIC Technologies from Bangalore, Silicon valley of India, in the emerging field of genome analytics”, both Dr Pellionisz and Mr. TD Prakash concurred. “Dr. Pellionisz will be our guiding force for foraying into Data Analysis of Next Gen Sequencing and Management, which we are offering to global clientele by early 2012”, added MV Ramanujam, VP of BINET Division, ELOGIC Technologies. As a domain expert in Genome Informatics, Dr. Pellionisz is a cross-disciplinary scientist and technologist. With Ph.D.-s in Computer Engineering, Biology and Physics, he has 45 years of experience in Informatics of Neural and Genomic Systems spanning Academia, Government and Silicon Valley Industry. He played a leading role in the shift from artificial intelligence to neural nets, including the establishment of the International Neural Network Society. In 2005, he combined interdisciplinary communities of Genomics and Information Technology when he established the International HoloGenomics Society (IHGS). Based on sound genome informatics, his work sets forth new mathematical principles for proceeding with full exploration of the whole genome. Dr. Pellionisz’ fractal approach to genome analysis is corroborated by recently published findings about fractal folding of DNA structure by Presidential Science Adviser Eric Lander. “I am very pleased to join the ELOGIC Technologies Advisory Board. I am convinced that they have the foundation essential for edging into genome informatics. As one who served the “Internet Boom” as Chief Software architect of several Silicon Valley companies, I see and publicly expressed already in 2008 two major differences in the coming much larger boom of Industrialization of Genomics. First, while Internet companies could charge ahead without scientific innovation as packet-switching technology is both man-made and is utterly simple, industrialization of genomics (like nuclear industry) would not only be naive but utterly dangerous without science leadership. Second, while the Internet Boom was essentially centered on Silicon Valley of California, the Genome Boom is already global. I not only realize the cardinal importance of an alliance of Silicon Valley of California with Bangalore, the Silicon Valley of India, but will enjoy building a spectacular success based on global alliance,” says Dr. Pellionisz. In 1973 Dr. Pellionisz was awarded a Stanford Post Doctoral Fellowship, subsequently he served as Research Professor of Biophysics at New York University Medical Center. Later at NASA Ames Research Center, as a Senior Research Associate of the National Academy. From 1994, he served as Chief Software Architect to several Silicon Valley companies. About ELOGIC Technologies ELOGIC Technologies is an IT Enabled Services Company serving a clientele of major multi- national and Government organisations seeking collaboration in the areas of Genome Informatics & Life Sciences, E-Security Services, Productivity Enhancement Solutions, Banking Solutions, Engineering Services and Professional Services Consultancy. Established in the year 2002, they aim at providing high quality, products and services to achieve customer satisfaction and to be an innovating Company in leading edge technologies. Contact MV RAMANUJAM Press Release by PRBuzz See original here Distinguished expert in genomics to advise DRC on technology and market plan SUNNYVALE, CA / PRBuzz / March 2, 2011 -- DRC Computer Corporation (DRC), the leading innovator of dynamically reconfigurable processors, announces that Dr. Andras Pellionisz is joining DRC's Advisory Board. Dr. Pellionisz is a recognized expert in the field of genome informatics specializing in the geometrization of biology, which he applied first in neuroscience to produce industrial neural net applications and later in genomics, manifesting today in applications for personal genomes. "I am delighted to welcome Andras to our Advisory Board. He brings a wealth of knowledge and contacts in genomics that will be valuable to DRC as we continue to build presence in this major market segment," said Larry Laurich, DRC President. As a domain expert in Genome Informatics, Andras Pellionisz is an interdisciplinary scientist and technologist. With Ph.D.'s in Computer Engineering, Biology and Physics, he has 45 years of experience in Informatics of Neural and Genomic Systems spanning Academia, Government and Silicon Valley Industry. Dr. Pellionisz played a leading role in the shift from artificial intelligence to neural nets, including the establishment of the International Neural Network Society. In 2005, he combined interdisciplinary communities of Genomics and Information Technology when he established the International HoloGenomics Society (IHGS). Based on sound genome informatics, his work sets forth new mathematical principles for proceeding with full exploration of the whole genome. Dr. Pellionisz' fractal approach to genome analysis is corroborated by recently published findings about fractal folding of DNA structure by Presidential Science Adviser Eric Lander. "I am very pleased to be joining the DRC Advisory Board. I am convinced that DRC has the foundation for the genome computer with their leading edge accelerator technology, and I will enjoy assisting them in developing the market for this," said Dr. Andras Pellionisz. In 2008, his breakthrough research: "The Principle of Recursive Genome Function", http://www.prweb.com/releases/genomics/biotechnology/prweb1102764.htm superseded the misnomer "Junk DNA". "Junk DNA", a term widely used for 30+ years to define intergenetic material, was as widely misunderstood and dismissed until HoloGenomics. It is now acknowledged as critical to understanding DNA. In 1973 Dr. Pellionisz was awarded a Stanford Post Doctoral Fellowship, subsequently he served as Research Professor of Biophysics at New York University Medical Center. Later at NASA Ames Research Center, as a Senior Research Associate of the National Academy. From 1994, he served as Chief Software Architect to several Silicon Valley companies. About DRC Computer Corporation http://www.drccomputer.com DRC Computer Corporation is the leading innovator of dynamically reconfigurable processors, addressing the needs of time-critical, data-intense applications in the defense and finance industries, security environments, web companies, and biomedical markets. Recently DRC announced a world performance record in bioinformatics achieving 9.4 trillion cell updates per second using the Smith-Waterman technique. Also this was achieved at a price/performance 5 times better than previous records. DRC's Accelium™ processors deliver ultra-high performance with very low energy usage (typically less than 25 watts) and minimal space requirements, producing actionable intelligence much faster (100x and more) and at significantly lower cost (90% lower) than traditional computer technologies. DRC is a wholly owned subsidiary of Security First Corp., an emerging industry leader in information assurance, data security, privacy, integrity, and high availability. Contact Press Release by MarketWire See original here Designed to automate best choices for consumers as they shop for nutrients, supplements, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, all controlled by user preferences to empower consumers with a practical tool to optimize health and maximize prevention. HolGenTech presented on stage and throughout the conference in the HolGenTech booth. The PGA uses a device’s bar code reader to capture product ingredient information and respond with personalized screens of recommendation advice and ratings that display on a scale of -10 to +10, corresponding to analysis of integrated data from multiple sources. The PGA user can automatically and immediately identify the personalized prevention efficacy of any product under consideration, as long as the product has a bar code for ingredients. Consumers are equipped to make quick, yet thorough, product comparisons that take into consideration personal health preferences and genomic information with special attention to a disease, syndrome, or health condition they wish to improve. See the YouTube of the HolGenTech PGA demonstration: “Shop for Your Life”. “A Genome Based Economy is upon us. Soon, awareness of our genome will allow us to use our genome to live in a way that constantly promotes personal health and well being. As we are aware of our genome, we realize that the genome is not our destiny, but rather it is affected by our choices. In the HolGenTech genome computing architecture we perform the analysis and provide the user tools to discover and make the best genomic and personal choices,” said HolGenTech founder Dr. Andras Pellionisz. “Through the HolGenTech genome computing architecture, we can provide answers as consumers respond to the compelling new paradigm and its imperative: Ask what you can do for your genome!” The HolGenTech PGA illustrates the practical application of the genome, emphasizing how personal genome analysis can be used as a tool for an individual to pursue all they can do to affect their genome. Disease prevention—or health—hinges on optimizing epigenomic pathways through foods, food additives, vitamins, cosmetics, chemicals, and environments to best fit or fix one’s genome. The HolGenTech genome computing architecture—where the PGA represents a mobile component—utilizes high performance parallel computing for genome analysis to search for both conventional structural variants and proprietary search of fractal defects, making the genome practically usable for consumers who want to make their best choices for living. HolGenTech featured its proprietary genome computing architecture in demonstrations of the PGA mobile application and the Personal Genome Computer (PGC). Also featured in the portfolio is a mobile application for Alzheimer patient tracking, ALZtrek, which utilizes a smartphone's GPS to track the whereabouts of early stage Alzheimer patients. HolGenTech is presently engaged in securing Series A or angel funding for a rapid ignition to ramp up implementation of the genome computing architecture. |
|
Press Release by PRWeb See original here HolGenTech Demonstrates first-ever PDA Combination with High Performance Genome Computing at Boston Consumer Genetics Conference See Press Release in HoloGenomics News June 19, 2009 A stunned audience embraced the Genome Based Economy when HolGenTech Founder Dr. Andras Pellionisz debuted the first-ever consumer application for genome computing architected with High Performance hybrid Genome PC combined with a Personal Digital Assistant at the Consumer Genetics Conference in Boston on June 10. Affecting individual choices and creating new awareness and understanding of how the world around us impacts the one within us, the personal genome used by PDA presented a new vision of customers tooling up for the future imposed on us by breakthrough genomics and computing. Sunnyvale, CA (PRWEB) June 19, 2009 -- The Google Phone demonstration introduced the imminent reality of the Genome Based Economy, as presented by HolGenTech Founder Dr. Andras Pellionisz at the "first ever" Consumer Genetics Conference in Boston the morning of June 10. Dr. Pellionisz demonstrated use of PDA for customers at the Consumer Genetics Conference in Boston in the morning of June 10. Within hours, Illumina's CEO Jay Flatley featured a different business model application for personal genomes in the Apple iPhone. The envisioned screenshots of handheld device applications intended for personal genomes stunned the audience of approximately 400 with a view into how practical applications of our personal genomes will change everything. Dr. Pellionisz illuminated the potential of the personal genome when applied to shopping in the Genome Based Economy. Using the Google Phone's built-in bar code reader, Dr. Pellionisz demonstrated how personal genome computing can detect genome-friendly and genome-supportive products from foods to cosmetics to building materials and beyond. In the envisioned application, the PDA user was assumed to have a genomic proclivity to Parkinson's disease. The demonstration leveraged the Google Phone's bar code reader to capture product information and a product rating scale to identify the prevention efficacy of any product under consideration. The consumer is equipped to make immediate product comparisons based on both personal health-preferences and genomic information with special consideration of the disease or syndrome of concern. The HolGenTech Google Phone demonstration illustrated practical application of the personal genome, emphasizing how Personal Genome Analysis can be used as a tool for an individual to pursue Personalized Consumer Activity based on one's DNA. The demonstration elucidated how disease prevention--or health--hinges on optimizing epigenomic pathways through foods, food additives, vitamins, cosmetics, chemicals, and environments to best fit or fix one's genome. In a completely different and contrasting model, Illumina's iPhone demonstration focused on reading one's genome information for the purpose of comparison to others'. The Personal Genome Computer -- a tool for the Genome Based Economy "The Personal Genome Computer is the catalyst tool for the Genome Based Economy. We look to chip-makers Intel, AMD, Xilinx, and Altera, and to integrators like HP, Dell, DRC, and even IT giants like Google and Microsoft, for next developments in parallel processing to produce HPC desktop- and server-lines as the IT infrastructure of the Genome Based Economy," said Dr. Andras Pellionisz. "As high performance computing, custom algorithms and post-ENCODE genomics align, more personalized medicine and health care, wellness, prevention, and DNA-informed personal and lifestyle choices are realized. With affordable access to and utility of our personalized genome we can experience personalized everything from health care to food to clothing to housing and environmental choices, even to friends....everything suited to one's personal genome." In the HolGenTech presentation in Boston, Pellionisz outlined the unprecedented computing-challenge posed by the oncoming avalanche of affordable full genome sequences which require in-depth analysis to be useful. Today "Direct-to-Customers" genome testing companies, such as DeCodeMe, 23andME, and Navigenics, rely on Illumina/Affymetrix microarray-technology to interrogate up to 1.6 million SNP-s (single nucleotide polymorphisms, point mutations of the 6.2 billion A,C,T,G letters/amino acid bases of human DNA), though the field of genomics is already beyond SNP-s and awaits the next developments in nano-sequencing technology, which promise affordable and readily available personal genomes by the second half of 2009. Landmark Principles in Action The Consumer Genetics Conference coincides with the second anniversary of the epoch-making release of ENCODE results, when mastermind Francis Collins, the most prominent keynote speaker at the Boston conference, declared, "the scientific community had to re-think long-held fundamentals." In response to Francis Collins' direct call, Dr. Pellionisz published one year ago the landmark paper The Principle of Recursive Genome Function. Emerging from the conference, a new consensus demands advanced computational mechanisms to search for much more complex (mal)formations of full DNA sequences. While the new Illumina microarray extends utility up to 4 million points and includes the ability to spot over 10 thousand "copy number variations," Pellionisz' research points to the problem of algorithmic, recursive genome regulation, where genome regulation derailments require intricate searches for cancer-stopping microRNA-s, silent mutations, repeat motifs and fractal defects. |